Breaking News
Get 45% Off 0
Is it finally time to sell Nvidia ahead of earnings?
Read More

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Friday's Rally Salvages Week By Zacks Investment Research - Feb 23, 2018

It was going to take a strong performance on Friday to give the market its second-straight positive week since the sharp pullback. And we got it! The major indices each jumped by more than 1%...

Tim Knight
U.S. Stocks Flash Key Upside Violation By Tim Knight - Feb 23, 2018

The first week of February was down hard. The second week was up hard. And now, the third week, is a total muddle. I won't pretend I’m not disappointed that things have stalled out like this,...

trade 12
PLNT Posts Earnings Beat By trade 12 - Feb 23, 2018

On Thursday, shares of Planet Fitness Inc. (NYSE:PLNT) were up by almost ten percent following the earnings report of the company that beat most analysts expectations. The company is known for its...

Al Brooks
Emini In Breakout Mode On Daily, Weekly Charts By Al Brooks - Feb 23, 2018

Pre-Open Market AnalysisYesterday closed near its open and therefore was a doji day. Furthermore, it was an inside day. There is now an ioi Breakout Mode setup on the daily chart. However, the 4-day...

Guy S. Ortmann, CMT
Near-Term Outlook Remains “Neutral/Positive”   By Guy S. Ortmann, CMT - Feb 23, 2018

Data Remains MixedOpinionThe indexes closed mixed Thursday with positive internals on the NYSE while NASDAQ internals were negative. Volumes declined on the NYSE and were flat on the NASDAQ. No...

Stephen Loke
Is Dow Forming Cup-And-Handle Pattern? By Stephen Loke - Feb 23, 2018 6

It has been a really wild ride for investors. The Dow Jones Industrial Average, the S&P 500 and the Nasdaq 100 Futures have all gone through one big rollercoaster ride. While volatility hurts the...

Zacks Investment Research
Abbvie's Uterine Fibrosis Candidate Meets Goal In Study By Zacks Investment Research - Feb 23, 2018

AbbVie Inc. ( (NYSE:ABBV) ) along with partner Neurocrine Biosciences, announced that the phase III study oftheir late stage candidateelagolix met its primary endpoint in women with uterine fibroids....

Zacks Investment Research
Express Scripts, Walgreens Tie Up To Cut Specialty Drug Price By Zacks Investment Research - Feb 23, 2018

In a bid to ensure availability of specialty brand drugs Express Scripts Holding Company (NASDAQ:ESRX) and Walgreens Boots Alliance (NASDAQ:WBA) recently announced plans to expand their existing...

Edison
US NanoTherm IDE Approval A Major Milestone   By Edison - Feb 23, 2018

Magforce AG (DE:MF6G) has received IDE approval to start its first pivotal clinical trial evaluating NanoTherm focal ablation therapy for prostate cancer in the US. This is a major milestone for the...

Ed Yardeni
Soarin’ Fundamentals For Stocks By Ed Yardeni - Feb 23, 2018

I spent the long President’s Day weekend with my family in Disney World. It was the first time that my four-year-old granddaughter Cecelia (a.k.a. “CeCe”) attended the theme park....

Kenny Fisher
DAX Edges Lower As German GDP Slows In Q4 By Kenny Fisher - Feb 23, 2018

The DAX index has posted slight losses in the Friday session. Currently, the index is trading at 12,437.00, down 0.20% on the day. On the release front, German Final GDP dipped to 0.6% for the fourth...

Zacks Investment Research
ETFs In Focus After Utilities Report Q4 Results By Zacks Investment Research - Feb 23, 2018

This earnings season has been a mixed bag for utilities, with some beating market expectations and others falling short of the same.We will now discuss the performance of three companies, Dominion...

Brett Owens
Four 6%+ Dividends With 15% to 20%+ Upside By Brett Owens - Feb 23, 2018

Most of your friends are going to struggle to make any money in U.S. stocks for the next five to seven years. They’re battling not one, not two, but three major headwinds: Low yields, High...

Continue with Apple
Continue with Google
or
Sign up with Email